IMCC
NASDAQ
IL
IM Cannabis Corp. - Common Shares
$0.34
▲ +$0.03
(+11.15%)
Vol 193K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$10.6M
ROE
-79.5%
Margin
-8.6%
D/E
296.36
Beta
2.25
52W
$2–$10
Wall Street Consensus
7 analysts · Oct 20232
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.13 | $-1.20 | $-1.32 |
| Jun 2025 | $-0.20 | $-0.10 | +$0.10 |
| Dec 2024 | $-0.55 | $-0.22 | +$0.33 |
| Sep 2024 | $-1.44 | $-0.41 | +$1.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… |
|---|---|---|---|---|
| Revenue | $13.9M | $13.3M | $12.5M | $12.7M |
| Net Income | -$922K | -$1.0M | $175K | -$309K |
Fundamentals Trend
| Metric | 2025-03-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.5% | -79.5% | -79.5% | -79.5% | -79.5% | -79.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 2.2% | -8.6% | -8.6% | -8.6% | -8.6% | -8.6% |
| Gross Margin | 27.6% | 18.6% | 18.6% | 18.6% | 18.6% | 18.6% |
| D/E Ratio | 296.36 | 296.36 | 296.36 | 296.36 | 296.36 | 296.36 |
| Current Ratio | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
Key Ratios
ROA (TTM)
-11.1%
P/S (TTM)
0.20
P/B
1.9
EPS (TTM)
$-2.06
CF/Share
$-1.10
Rev Growth 3Y
+16.6%
52W High
$9.70
52W Low
$1.75
$1.75
52-Week Range
$9.70
Financial Health
Free Cash Flow
-$478K
Net Debt
$14.9M
Cash
$794K
Total Debt
$15.7M
As of Jun 30, 2025
How does IMCC compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
IMCC valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.2
▼
96%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.9
▼
10%
below
peers
(2.1)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
IMCC profitability vs Pharmaceuticals peers
ROE
-79.5%
▼
46%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-8.6%
▲
82%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
18.6%
▼
73%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-11.1%
▲
70%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
IMCC financial health vs Pharmaceuticals peers
D/E ratio
296.4
▲
19144%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
0.7
▼
78%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
2.3
▲
139%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
IMCC fundamentals radar
IMCC
Peer median
Industry
IMCC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IMCC vs peers: key metrics
Latest News
No related news yet